Cytokinetics (CYTK)
Cytokinetics EBITDA TTM: -45.10M
View CYTK EBITDA TTM with YCharts Pro.
Access these YCharts Pro features:
Export any data you want
Save any chart as an image
Utilize advanced screener power
View 30 years of financial history
over 90 advanced calculations
Enjoy an advertising free experience
CYTK EBITDA TTM Rankings
| Overall | 3rd percentile | 3824 of 3956 |
| Sector | 8th percentile | 460 of 504 in Healthcare |
| Industry | 18th percentile | 125 of 154 in Biotechnology |
CYTK EBITDA TTM Range, Past 5 Years
| Minimum | -60.35M | Sep 2008 |
| Maximum | 29.44M | Sep 2009 |
| Average | -35.85M |
About EBITDA (TTM)
EBITDA is an abbreviation for earnings before interest, taxes, depreciation, and amortization. EBITDA (TTM) is the sum of the last four quarters of EBITDA.
Investors often use EBITDA as a starting point for discounted cash flow analysis or to observe the performance of a business separately from its capital structure (debt vs equity financing structure).
Though EBITDA does form an excellent basis for cash flow analysis, some investors argue that it is a misleading measure since depreciation expenses are a real cost - old property, plant and equipment must eventually be replaced if a business plans to continue operations using those assets.
Learn More
You may also be interested in these CYTK related companies
CYTK News
$CYTK forms bearish "Continuation Diamond" chart pattern. http://stks.co/3aqN
about 28 days ago by RecogniaEvents
about 28 days ago by RecogniaEvents
@Jamtrades @seekingalpha when they use the term encouiraging it usually means its crap $CYTK
about 33 days ago by lieberlanz
about 33 days ago by lieberlanz
Cytokinetics (CYTK) Proposed Muscle Troponin Activator Now on FDA's Fast Track
Apr 19, 8:53AM Street Insider
Apr 19, 8:53AM Street Insider
$CYTK forms bearish "Head and Shoulders Top" chart pattern. http://stks.co/3IOW
about 48 days ago by RecogniaEvents
about 48 days ago by RecogniaEvents
$CYTK filed latest Proxy Statement with the SEC (Form DEF 14A) http://stks.co/3BjU
about 56 days ago by MarketBrief
about 56 days ago by MarketBrief
Cytokinetics to Present at the Eleventh Annual Needham Life Sciences Conference
Mar 27, 4:13PM Marketwire
Mar 27, 4:13PM Marketwire
@ChiBullsTrader @ChillzTrading Agree! May add position for that event; already have $CYTK for the same conference.
about 68 days ago by Chilltill
about 68 days ago by Chilltill
$CYTK forms bullish "Diamond Bottom" chart pattern. http://stks.co/2kad
about 81 days ago by RecogniaEvents
about 81 days ago by RecogniaEvents
Cytokinetics, Inc. (CYTK) Posts Q4 Loss of 16c/Share; Guides FY12 Revs
Feb 02, 4:13PM Street Insider
Feb 02, 4:13PM Street Insider
Cytokinetics, Incorporated Reports Fourth Quarter and Year End Highlights and 2011 Financial Results
Feb 02, 4:00PM Marketwire
Feb 02, 4:00PM Marketwire
Cytokinetics to Announce Fourth Quarter and Year End Results on February 2, 2012
Jan 26, 4:00PM Marketwire
Jan 26, 4:00PM Marketwire
Cytokinetics (CYTK) Reports Positive CK-2017357 Phase II, Part A Dat in ALS Patients
Nov 30, 7:32AM Street Insider
Nov 30, 7:32AM Street Insider
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| CYTK | 0.93 | +0.02 | +2.20% | 71.03M |
| CVBK | 0.86 | -0.08 | -8.51% | 2.262M |
| CVA | 15.79 | -0.03 | -0.19% | 2.149B |
| CV | 35.13 | -0.02 | -0.06% | 473.55M |
| CUZ | 7.42 | +0.09 | +1.23% | 772.72M |
| CUTR | 6.94 | -0.20 | -2.80% | 96.81M |
| CUT | 16.04 | +0.04 | +0.24% | |
| CURE | 39.59 | +0.00 | +0.00% | |
| CUR | 0.94 | -0.01 | -1.05% | 51.40M |
| CUK | 32.44 | +0.02 | +0.06% | 6.977B |
